default author photo

Ahmed Nadeer

GlaxoSmithKline - Pennsylvania

1250 S Collegeville Rd.

Collegeville, 19426

United States

  • GlaxoSmithKline - Pennsylvania

SCHOLARLY PAPERS

1

DOWNLOADS

74

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

An Open-Label Phase Ii Trial of Sotrovimab (Vir-7831) Prophylaxis Against Covid-19 Infection in Immunocompromised Individuals with Impaired Sars-Cov-2 Humoral Immunity

Number of pages: 33 Posted: 21 Mar 2025
Isabel H. Gonzalez-Bocco, Rayven Frierson, Alyssa Cho, Fabiola A. Reyes, Andres E. Fraceschi, Chloe Lahoud, Dimitrios Moshovitis, Katherine Beluch, Manu Balusu, Catherine Keleher, Keri Sullivan, Michael Dougan, Qianwen Wang, Jennifer Han, Ahmed Nadeer, Alicia Aylott, Wei Wang, Brian T. Chan, Sarah P. Hammond, Jennifer Manne-Goehler and Sophia Koo
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Tufts University - Tufts Medical Center, affiliation not provided to SSRN, Staten Island University Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, GlaxoSmithKline, affiliation not provided to SSRN, GlaxoSmithKline - Pennsylvania, affiliation not provided to SSRN, Harvard University, affiliation not provided to SSRN, affiliation not provided to SSRN, Harvard University - Brigham and Women's Hospital and affiliation not provided to SSRN
Downloads 74 (844,901)

Abstract:

Loading...

immunocompromised host, COVID-19, pre-exposure prophylaxis, monoclonal antibodies